Genetic testing has grown too complex for traditional oversight models:

175,000+ tests on the market, with 10+ added daily

Increased waste and fraud from inappropriate utilization

Delayed or inconsistent coverage decisions

Fragmented lab access and misaligned test adoption

Rising regulatory scrutiny around prior authorization

These issues drive cost, create compliance risk, and strain both payers and labs.

Avalon

Avalon turns adopted evidence-based lab policies into guidance to ensure genetic testing is medically appropriate.

For Health Plans

  • Science-backed coverage criteria developed by laboratorians, geneticists, and an independent Clinical Advisory Board
  • Gold Carding & PA relief for top-performing labs using NCQA-aligned audits
  • NCQA-accredited utilization management to ensure consistent, evidence-based decisions
  • Real-time lab network oversight for utilization patterns, performance tracking, and audit reviews
  • Claims-to-auth matching using advanced automation to reduce manual reviews and improve accuracy
  • Compliance oversight to address evolving regulatory requirements without adding administrative burden

For Labs

  • AvalonSelect Genetic Network (ASGN): Streamlined access to multiple payers through a single agreement
  • Transparent reimbursement: National fee schedules, direct contracting, and claims reconciliation for predictable payments
  • Lab Technology Evaluation (LTE): Accelerated policy development for new tests
  • Dedicated lab support: Ongoing onboarding, coding clarity, and appeals assistance